Of the more than $1.7 billion that Texas biotechnology companies raised from investors over the last six months, San Antonio's share was just over $3 ...
News
- San Antonio losing Texas race for biotech funding by wide margin
- EU regulators start review of China's Sinovac vaccine
The agency also is conducting rolling reviews of three other vaccines: the one developed by German biotech company CureVac, the American- ...
- Ultragenyx: Q1 Earnings Snapshot
The biotechnology company posted revenue of $99.4 million in the period, which beat Street forecasts. Seven analysts surveyed by Zacks expected ...
- Cerus: Q1 Earnings Snapshot
... Concord, California-based company said it had a loss of 10 cents. The biomedical products company posted revenue of $23.4 million in the period.
- PRP Topical Skin Care
Vivian Bucay, MD, discusses the evolution of topical growth factors using Aesthetics Biomedical's SoMe Skincare. Vivian Bucay, MD, Bucay Center for Dermatology and Aesthetics, San Antonio, Texas, recently spoke with Aesthetic ...